Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Prostate cancer patients receiving androgen deprivation therapy may have higher heart failure risk

Androgen deprivation therapy was associated with a 72 percent higher risk of heart failure in a study of patients with prostate cancer.

7 Nov 2018

Study highlights need for interventions to improve statin use among older adults

In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.

7 Nov 2018

Fish-rich and vegetarian diet may reduce hypertension-related heart disease symptoms

Elevated levels of trimethylamine N-oxide--a compound linked with the consumption of fish, seafood and a primarily vegetarian diet--may reduce hypertension-related heart disease symptoms.

7 Nov 2018

PTSD associated with increased risk of major CV event or death after cardiac arrest

People who experience post-traumatic stress disorder (PTSD) after surviving cardiac arrest, may be at a significantly increased risk of a major cardiovascular event or death for up to one year following the arrest, compared with people who do not develop PTSD.

6 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

UA professor wins NIH grant to advance research in preventing heart failure

A University of Arizona College of Medicine - Phoenix researcher has received a $393,493 grant from the National Institutes of Health to further her research in reducing the risk of heart failure in patients with high blood pressure.

1 Nov 2018

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

1 Nov 2018

Researchers discover biomarker for most common type of heart failure

A team led by a Cedars-Sinai physician-scientist has discovered a biomarker--a protein found in the blood--for the most common type of heart failure, a new study published today in JAMA Cardiology shows.

1 Nov 2018

Individual heart cells respond differently to high blood pressure

A team of cardiologists have found that single cells within the heart are affected by high blood pressure in different ways. Some adapt, whilst others fail.

30 Oct 2018

Individual cells within the same heart cope differently with high blood pressure, study shows

Individual cells within the same heart cope differently with high blood pressure, according to a study in human cells and mice by a team of cardiologists and computational biologists at the University of Tokyo.

30 Oct 2018

Researchers integrate several technologies to design new digital stethoscope

Researchers developed a new digital stethoscope that combines precision sensors, electrocardiogram technology and machine learning applications into one piece of equipment to better detect heart ailments and problems that might occur with an implanted heart pump.

26 Oct 2018

Study explores whether wearable patches could help patients to monitor blood pressure

Because only half of the people in the United States diagnosed with high blood pressure have their condition under control, an easy, cost-effective method to monitor blood pressure would be a significant advance to reduce the risk of heart disease and stroke.

25 Oct 2018

People with periodontal disease less likely to reach healthy blood pressure ranges

People with high blood pressure taking medication for their condition are more likely to benefit from the therapy if they have good oral health, according to new research in the American Heart Association's journal Hypertension.

22 Oct 2018

Research aims to address health disparities in African-American men

The burden of risk factors for chronic disease is substantially higher in black men compared with their white counterparts, including a higher prevalence of obesity and hypertension.

17 Oct 2018

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.

16 Oct 2018

Study uncovers important role of PRMT1 in dilated cardiomyopathy

In a study published in iScience, Professor Akiyoshi Fukamizu of the Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (University of Tsukuba, JAPAN) and the research group reported a new work on discovery of the important role of PRMT1 in dilated cardiomyopathy.

16 Oct 2018

Heart Failure News and Research

Further Reading

Prostate cancer patients receiving androgen deprivation therapy may have higher heart failure risk

Study highlights need for interventions to improve statin use among older adults

Fish-rich and vegetarian diet may reduce hypertension-related heart disease symptoms

PTSD associated with increased risk of major CV event or death after cardiac arrest

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

UA professor wins NIH grant to advance research in preventing heart failure

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Researchers discover biomarker for most common type of heart failure

Individual heart cells respond differently to high blood pressure

Individual cells within the same heart cope differently with high blood pressure, study shows

Researchers integrate several technologies to design new digital stethoscope

Study explores whether wearable patches could help patients to monitor blood pressure

People with periodontal disease less likely to reach healthy blood pressure ranges

Research aims to address health disparities in African-American men

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Study uncovers important role of PRMT1 in dilated cardiomyopathy

Researchers develop comprehensive molecular atlas of postnatal mouse heart development

Will Maine voters decide to make aging in place affordable?

Discovery of gene mutation could offer benefit for people suffering from diabetes, heart disease, obesity

Micropeptide molecule could be promising gene therapy target to treat heart failure

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News